Hester Biosciences profit increased 6.09% in (Q1) FY 2020-21

Source

Team Infinities:

Hester Biosciences Limited NSE Symbol:HESTERBIO, BSE Security Code:524669 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.

Revenue Reported by Hester Biosciences Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
40.55 48.41 45.33
Calculated Revenue of Hester Biosciences Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
7.86 16.24%(Revenue Decrease) 4.78 10.54%(Revenue Decrease)

Revenue: Hester Biosciences Limited's financial report shows that the company's revenue decreased by 16.24% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.7.86 crores, as the company posted revenue of Rs.40.55 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.48.41 crores.
The result also shows that the company's revenue decreased by 10.54% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue decrease of Rs.4.78 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.45.33 crores.

Gross Margin(%) Reported by Hester Biosciences Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
83.98 67.79 75.52
Calculated Gross Margin(%) of Hester Biosciences Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
16.19 23.88%(GM Increase) 8.46 11.20%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 23.88% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 16.19% GM increase, as the company reported 83.98% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 67.79% GM.
The result also indicates, the company's GM increased by 11.20% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 8.46% GM increase; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 75.52% GM.

EBITDA Reported by Hester Biosciences Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
12.60 11.98 18.16
Calculated EBITDA of Hester Biosciences Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.62 5.18%(EBITDA Increase) 5.56 30.62%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 5.18% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.0.62 crore, as the company posted EBITDA of Rs.12.60 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.11.98 crores.
The result also shows that the company's EBITDA decreased by 30.62% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA decrease of Rs.5.56 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.18.16 crores.

Profit and Loss Reported by Hester Biosciences Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
5.05(Profit ) 4.76(Profit ) 8.09(Profit )
Calculated Profit and Loss of Hester Biosciences Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.29 6.09%(Profit Increase) 3.04 37.58%(Profit Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 6.09% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit increase of Rs.0.29 crore, as the company posted profit of Rs.5.05 crores; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.4.76 crores.
The result also shows that the company's profit decreased by 37.58% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit decrease of Rs.3.04 crores; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.8.09 crores.

EPS Reported by Hester Biosciences Limited for First Quarter FY, 2020-21
Current Quarter (April, 2020 - June, 2020) Previous Quarter (January, 2020 - March, 2020) Corresponding Quarter (April, 2019 - June, 2019)
5.94 5.60 9.51
Calculated EPS of Hester Biosciences Limited for First Quarter FY, 2020-21
Current(June, 2020) VS Previous(March, 2020) Current(June, 2020) VS Corresponding(June, 2019)
Change Change % Change Change %
0.34 6.07%(EPS Increase) 3.57 37.54%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 6.07% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.0.34, as the company posted EPS of Rs.5.94; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.5.60.
The result also shows that the company's EPS decreased by 37.54% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS decrease of Rs.3.57; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.9.51.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.